Follow us on:

Sativa Wellness Group FSA regulation key to industry and to the Group (Interview)

Sativa Wellness Group Inc. (CNSX:SWEL) Executive Chairman Geremy Thomas joins DirectorsTalk Interviews to discuss its novel food application to the FSA. Geremy explains why he has re-joined the board, the significance of the application announcement and the recent success of new listings in this CBD sector.

Sativa Wellness Group goal is to build Europe’s leading CBD Wellness brands, to meet today’s fast evolving consumer expectations. Through full vertical integration of their supply chain, they plan to become one of the premier low-cost producers and high-quality distributors of CBD wellness products in Europe.

Find more news, interviews, share price & company profile here for:Goodbody Health

Share this interview

Other Interviews

More News

Sativa Wellness Group Rule 19.6(c) Takeovers and Mergers update September 3, 2021
Sativa Wellness Group announces German distribution agreement for Goodbody Brand August 24, 2021
Sativa Wellness Group Revenue 828% higher Q2 2021 vs comparative quarter 2020 August 12, 2021
Sativa Wellness Group announces the opening of its 40th clinic and listing on Patient Access June 22, 2021
Sativa Wellness Group research paper on effects of cannabinoids on lung inflammation now published June 9, 2021
Sativa Wellness Group “Q2 has started very strongly” May 25, 2021
Sativa Wellness Group Inc. Announces Closing of Second and Final Tranche of $4.6 Million Private Placement May 21, 2021
Sativa Wellness Group turnover 38% increase on the previous year May 4, 2021
Sativa Wellness Group appoint Marc Howells as CEO and Anne Tew as CFO April 28, 2021
Sativa Wellness Groups Laboratory achieves ISO17025 Accreditation April 21, 2021

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.